Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agents.
about
Risk of cardiovascular adverse events in patients with solid tumors treated with ramucirumab: A meta analysis and summary of other VEGF targeted agents.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@ast
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@en
type
label
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@ast
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@en
prefLabel
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@ast
Risk of cardiovascular adverse ...... of other VEGF targeted agents.
@en
P1476
Risk of cardiovascular adverse ...... of other VEGF targeted agents
@en
P2093
Hesham ElHalawani
Omar Abdel-Rahman
P304
P356
10.1016/J.CRITREVONC.2016.04.003
P577
2016-04-22T00:00:00Z